Please enable Javascript to use all features and improve your user experience.
ESHO 2024
Programme
People
Search
EN
All people
Dr. Andreas Jordan
Berlin / DE
MagForce NT GmbH
Sort by Type
Date
Speaker
08/11/2024
09:32
–
09:44
9 Min.
3 Min.
Oral Presentation
OP-30
Interim results of the european registry study for the treatment of recurrent glioblastoma (2019-2023) using the NanoTherm Therapy System (NTTS)
Hyperthermia clinical applications: radio-chemo-immunotherapy
Further involvements
08/11/2024
09:32
–
09:44
9 Min.
3 Min.
Oral Presentation
OP-30
Interim results of the european registry study for the treatment of recurrent glioblastoma (2019-2023) using the NanoTherm Therapy System (NTTS)
Hyperthermia clinical applications: radio-chemo-immunotherapy
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy